"
Team:Goettingen/project overview/perspectives
From 2014.igem.org
(Difference between revisions)
m |
|||
| Line 13: | Line 13: | ||
<!-- right column--> | <!-- right column--> | ||
<div class="proRP" id="rpart1"> | <div class="proRP" id="rpart1"> | ||
| - | <div id="goenext"><a | + | |
| - | <h1 ><center><b>Further perspectives</b><center></h1> | + | <div id="goenext"><a id="prev"><img id="pButton"></a> 2/15 <a id="next"><img id="nButton"></a></div> |
| + | |||
| + | |||
| + | <br /><br /><br /> | ||
| + | <h1><center><b>Further perspectives</b><center></h1> | ||
<br /> | <br /> | ||
<br /> | <br /> | ||
| Line 46: | Line 50: | ||
}(document, 'script', 'facebook-jssdk'));</script> | }(document, 'script', 'facebook-jssdk'));</script> | ||
<br /><br /> | <br /><br /> | ||
| - | <div id="goenext"><a | + | |
| + | <div id="goenext"><a id="prev"><img id="pButton"></a> 2/15 <a id="next"><img id="nButton"></a></div> | ||
| + | |||
| + | <br /> | ||
<div class="fb-like" data-layout="standard" data-action="like" data-show-faces="true" data-share="true"></div> | <div class="fb-like" data-layout="standard" data-action="like" data-show-faces="true" data-share="true"></div> | ||
<script> | <script> | ||
| Line 78: | Line 85: | ||
e.preventDefault(); // prevent the default action (scroll / move caret) | e.preventDefault(); // prevent the default action (scroll / move caret) | ||
});</script> | });</script> | ||
| + | <script> | ||
| + | $( "[id=next]" ).attr("href", url13); | ||
| + | $( "[id=prev]" ).attr("href", url11); | ||
| + | $( "[id=nButton]" ).attr("src", nextButton).attr("width", "40"); | ||
| + | $( "[id=pButton]" ).attr("src", prevButton).attr("width", "40"); | ||
| + | </script> | ||
| + | |||
| + | |||
</body> | </body> | ||
</html> | </html> | ||
Revision as of 15:58, 26 September 2014
Project
Further perspectives
We have attained two milestones as far as the applications of our project is concerned. First,is the generation of peptides with an affinity to fungal surface molecules and second, is the proof of principle that our selection scheme can be used to generate peptides with affinity to a molecule under scrutiny. Both milestones hold promise but before that, we would like to elaborate on the future scope of the first milestone since it bears relevance to medicine and healthcare.
